Evaluation of leukocyte-depleted platelet concentrates obtained by in- line filtration

Vox Sanguinis

Volumn 78, Issue 4, 2000, Pages 235-241

  Ferrer, F ^a   Rivera, J ^a   Corral, J ^a   Gonzalez Conejero R ^a   Vicente, Vicente García ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; BLOOD CLOTTING FACTOR; CD63 ANTIGEN; CYTOKINE; GLYCOPROTEIN IB; GLYCOPROTEIN IIB; INTERLEUKIN 6; INTERLEUKIN 8; PADGEM PROTEIN; THROMBOCYTE CONCENTRATE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BLOOD FILTRATION; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; GLYCOPROTEIN SYNTHESIS; HUMAN; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION; THROMBOCYTE RICH PLASMA; THROMBOPLASTIN TIME;

EID: 0033909629     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000031187     Document Type: Article

References (38)

1. Lane TA: Leukocyte depletion of cellular blood components. Curr Opin Hematol 1994;1:443-451.
2. Norfolk DR, Williamson LM: Leucodepletion of blood products by filtration. Blood Rev 1995;9:7-14.
3. The Trial to Reduce Alloimmunization to Platelets Study Group: Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997; 337:1861-1869.
4. Menitove JE, Snyder EL: Platelet transfusion practice: Time for renewed consensus. Transfusion 1998;38:707-709.
5. Popovsky MA: Quality of blood components filtered before storage and at the bedside: Implications for transfusion practice. Transfusion 1996;36:470-474.
6. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, Kelton JG: The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-628.
7. Muylle L: The role of cytokines in blood transfusion reactions. Blood Rev 1995;9:77-83.
8. Ramos RR, Curtis BR, Duffy BF, Chaplin H: Low retention of white cell fragments by polyester fiber white cell-reduction platelet filters. Transfusion 1994;34:31-34.
9. Sweeney JD, Holme S, Heaton WAL, Nelson E: White cell-reduced platelet concentrates prepared by in-line filtration of platelet-rich plasma. Transfusion 1995;35:131-136.
10. Aye MT, Palmer DS, Giulivi A, Hashemi S: Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995;35:117-124.
11. Engelfriet CP, Reesink HW: The use and quality control of leukocyte-depleted cell concentrates. Vox Sang 1998;75:82-92.
12. Rivera J, Sánchez-Roig MJ, Rosillo MC, Moraleda JM, Vicente V: Stability of glycoproteins Ib/IX and IIb/IIIa during preparation and storage of platelet concentrates: Detection by binding assays with epitope-defined monoclonal antibodies and physiological ligands. Vox Sang 1994;67:166-171.
13. Lozano ML, Rivera J, Gońzalez-Conejero R, Moraleda JM, Vicente V: Loss of high-affinity thrombin receptors during platelet concentrate storage impairs the reactivity of platelets to thrombin. Transfusion 1997;37:368-375.
14. British Committee for Standards in Haematology (BCSH): Guidelines on the clinical use of leukocyte-depleted blood components. Transfusion Med 1998;8:59-71.
15. Menitove JE (ed): Standards for Blood Banks and Transfusion Services, ed. 18. Bethesda, American Association of Blood Banks, 1997.
16. Rebulla P, Bertolini F, Parravicini A, Sirchia G: Leukocyte-poor blood components: A purer and safer transfusion product for recipients. Transfus Med Rev 1990;4(suppl 1):19-23.
17. Wieding JU, Vehmeyer K, Dittman J, Hiddemann W, Köhler M, Lanzer G: Contamination of fresh-frozen plasma with viable white cells and proliferable stem cells (letter). Transfusion 1994;34:185-186.
18. Willis JI, Lown JAG, Simpson MC, Erber WN: White cells in fresh-frozen plasma: Evaluation of a new white cell-reduction filter. Transfusion 1998;38:645-649.
19. Wieding JU, Hellstem P, Kühler M: Inactivation of viruses in fresh-frozen plasma. Ann Hematol 1993;67:259-266.
20. Devine DV, Bradley AJ, Maurer E, Levin E, Chahal S, Serrano K, Gyongyossy-Issa MIC: Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems. Transfusion 1999;39:724-734.
21. Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME: Increased tumor necrosis factor-α (TNF-α) interleukin-1, and interleukin-6 (IL-6) levels in the plasma of stored platelet concentrates: Relationship between TNF-a and IL-6 levels and febrile transfusion reactions. Transfusion 1993;33:195-199.
22. Muylle L, Wouters E, Peetermans ME: Febrile reactions to platelet transfusion: The effect of increased interleukin-6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion 1996;36:886-890.
23. Sarkodee-Adoo CB, Kendall JM, Sridhara R, Lee EJ, Schiffer CA: The relationship between the duration of platelet storage and the development of transfusion reactions. Transfusion 1998;38:229-235.
24. Heddle NM, Klama L, Meyer R, Walker I, Boshkov L, Roberts R, Chambers S, Podlosky L, O'Hoski P, Levine M: A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion 1999;39:231-238.
25. Muylle L, Peetermans ME: Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang 1994;66:14-17.
26. Wadhwa M, Seghatchian MJ, Lubenko A, Contreras M, Dilger P, Bird C, Thrope R: Cytokine levels in platelet concentrates: Quantitation by bioassays and immunoassays. Br J Haematol 1996;93:225-234.
27. Wahl SM: Transforming growth factor beta in inflammation: A cause and a cure. J Clin Immunol 1992;12:61-74.
28. Miletic VD, Popovic O: Complement activation in stored platelet concentrates. Transfusion 1993;33:150-154.
29. Schleuning M, Böck M, Mempel W: Complement activation during storage of single donor platelet concentrates. Vox Sang 1994;67: 144-148.
30. Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Dalmasso AP, Jacob HS: Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977; 296:769-774.
31. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW: Complement activation during cardiopulmonary bypass. N Engl J Med 1981;304:497-503.
32. Hammerschmidt DE, Craddock PR, McCullough J, Kronenberg RS, Dalmasso AP, Jacob HS: Complement activation and pulmonary leukostasis during nylon fiber filtration leukapheresis. Blood 1978;721-730.
33. Pixley RA, Schmaier A, Colman RW: Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor. Arch Biochem Biophys 1987;256:490-498.
34. Colman RW: Surface-mediated defense reactions: The plasma contact activation system. J Clin Invest 1984;73:1249-1253.
35. Bode AP, Miller DT, Newman SL, Catellani WJ, Norris HT: Plasmin activity and complement activation during storage of citrated platelet concentrates. J Lab Clin Med 1989; 113:94-102.
36. Wallvik J, Suontaka AM, Blombäck M: Proteolytic activity during storage of platelets in plasma. Transfusion Med 1992;2:135-142.
37. Riggert J, Schwartz DWM, Wieding JU, Mayr WR, Köhler M: Prestorage in-line filtration of whole blood for obtaining white cell-reduced blood components.Transfusion 1997;37:1039-1044.
38. Sanz C, Reverter JC, Escolar G, Mazzara R, Pereira A, Ordinas A: Platelet activation and thrombin generation in the obtention of platelets for transfusion (abstract). Thromb Haemost 1993;69:927.